Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status
Glioblastoma (GBM) is the most common and aggressive malignant brain tumor. Standard treatments including surgical resection, radiotherapy, and chemotherapy, have failed to significantly improve the prognosis of glioblastoma patients. Currently, immunotherapeutic approaches based on vaccines, chimer...
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
MDPI AG
2024-06-01
|
| Serie: | Vaccines |
| Ämnen: | |
| Länkar: | https://www.mdpi.com/2076-393X/12/6/655 |